This article has Open Peer Review reports available.
Cardiac tamponade mimicking tuberculous pericarditis as the initial presentation of chronic lymphocytic leukemia in a 58-year-old woman: a case report
© Lin et al; licensee BioMed Central Ltd. 2010
Received: 21 October 2009
Accepted: 4 August 2010
Published: 4 August 2010
Chronic lymphocytic leukemia is an indolent disease that often presents with complaints of lymphadenopathy or is detected as an incidental laboratory finding. It is rarely considered in the differential diagnosis of patients presenting with tamponade or a large, bloody pericardial effusion. In patients without known cancer, a large, bloody pericardial effusion raises the possibility of tuberculosis, particularly in patients from endemic areas. However, the signs, symptoms and laboratory findings of pericarditis related to chronic lymphocytic leukemia can mimic tuberculosis.
We report the case of a 58-year-old African American-Nigerian woman with a history of travel to Nigeria and a positive tuberculin skin test who presented with cardiac tamponade. She had a mild fever, lymphocytosis and a bloody pericardial effusion, but cultures and stains were negative for acid-fast bacteria. Assessment of blood by flow cytometry and pericardial biopsy by immunohistochemistry revealed CD5 (+) and CD20 (+) lymphocytes in both tissues, demonstrating this to be an unusual manifestation of early stage chronic lymphocytic leukemia.
Although most malignancies that involve the pericardium clinically manifest elsewhere before presenting with tamponade, this case illustrates the potential for early stage chronic lymphocytic leukemia to present as a large pericardial effusion with tamponade. Moreover, the presentation mimicked tuberculosis. This case also demonstrates that it is possible to treat chronic lymphocytic leukemia-related pericardial tamponade by removal of the fluid without chemotherapy.
Chronic lymphocytic leukemia (CLL) is an indolent disease that often presents with complaints of lymphadenopathy and fatigue or is detected as an incidental laboratory finding. Although leukemias represent only about eight percent of neoplastic metastases to the heart, almost 50% of lymphoma patients have cardiac involvement at autopsy . Pericardial effusions or cardiac tamponade are relatively uncommon as presenting syndromes in patients with hematologic malignancies [2, 3]. Likewise, hematologic malignancies account for a minority of pericardial effusions. Imazio et al found that only 33 (7.3%) of 450 patients with acute pericardial disease had a neoplastic etiology. The most powerful clinical predictor of a neoplastic etiology was a history of malignancy (odds ratio 19.8) . Lung and breast cancers are the most common neoplasms causing pericardial effusion . In a series of 150 cases of cardiac tamponade requiring pericardiocentesis, 64% had sanguinous pericardial fluid. The most common causes of the effusions were iatrogenic (31%), followed by malignancy (26%) . Only a handful of cases have described cardiac involvement in CLL and these reports described patients with established CLL, rather than patients presenting with tamponade and being subsequently discovered to have CLL [2, 6–8]. We present the case of a woman whose initial presentation of CLL was cardiac tamponade with sanguinous pericardial fluid but whose history and clinical presentation was suspicious for tuberculous pericarditis.
A 58-year-old African American-Nigerian woman with a week-long history of progressive shortness of breath presented to our emergency room. She had lived in Benin, Nigeria until nine years earlier and had been back for a one-month-long visit three years prior to presentation. She had previously been in excellent health until one week prior to admission. Over the week she became dyspneic with minor exertion and could no longer climb one flight of stairs without pausing to rest. She denied any chest pain, but described a sense of 'congestion' in her chest, which progressed over the week. The patient had a subjective fever that began at the same time as the dyspnea and which was relieved by acetaminophen. Her past medical history was significant for hypertension (treated with hydrochlorothiazide and amlodipine) and a positive tuberculin skin test.
On physical examination, her vital signs included a heart rate of 100 and blood pressure of 134/94 with a pulsus paradoxus of over 15 mm Hg. Her cardiovascular examination revealed distant heart sounds, normal first and second heart sounds and no murmurs, rubs or knocks. There was jugular venous distention to 20 cm above the manubriosternal angle. The lung examination was unremarkable. Her abdomen was soft and nondistended. There was no peripheral edema, adenopathy or hepatosplemogaly.
Initial Lab Values
White Blood Cell (3.5 to 11 k/uL)
Red Blood Cell (3.88 to 5.26 M/uL)
Absolute Lymphocytes (0.9 to 3.3 K/uL)
Absolute Reactive Lymphocytes
Absolute Monocytes (0.16 to 0.92 K/uL)
Hemoglobin (11.5 to 15.5 g/dL)
Hematocrit (36 to 47%)
Sodium (134 to 149 mEq/L)
Potassium (3.3 to 4.7 mEq/L)
Chloride (95 to 108 mEq/L)
Carbon Dioxide (23 to 30 mEq/L)
Blood Urea Nitrogen (7 to 20 mg/dL)
Creatinine (0.5 to 1.4 mg/dL)
SGOT (8 to 37 U/L)
SGPT (8 to 35 U/L)
D-Dimer Assay (<0.42 ug/ml)
Ferritin (10 to 220 ng/mL)
ANA titer (0 to 80)
Anti-ds DNA (<10 titer)
The pericardial fluid contained 2,680,000 red blood cells and 8,500 leukocytes/uL. The leukocyte differential was 33% neutrophils, 56% lymphocytes, 6% macrophages, 2% mesothelial cells and 3% eosinophils. Fluid analysis showed that the fluid glucose was 59 mg/dl, fluid lactate dehydrogenase was 325 IU/L, and total protein was 4.5 g/dl. Staining of the fluid for acid-fast bacilli was negative, as were bacterial cultures. Fluid cytology revealed only reactive mesothelial cells.
Because of persistent concern about possible tuberculous pericarditis and lack of a definitive diagnosis, a pericardial window was performed from a subxiphoid approach. On gross examination, the thickened pericardium measured between 0.1 and 0.3 cm. However, acid-fast stains and culture remained negative.
On the sixth day after admission, the daily complete blood count with differential was notable for the presence of immunoblasts. Flow cytometry of peripheral blood for lymphocyte subsets was performed. A repeat echocardiogram did not demonstrate reaccumulation of pericardial fluid and the patient remained asymptomatic and was discharged home for outpatient evaluation.
The patient was seen in follow-up at one year and has remained free from symptomatic disease without any chemotherapy. Echocardiography demonstrated that her pericardial effusion had not recurred.
The etiologies of sanguinous pericardial effusions causing tamponade, excluding iatrogenic causes, include malignancy, renal failure and/or uremia and tuberculosis, although the latter is now uncommon in North America . Our initial high suspicion for tuberculous pericarditis was based on her history, the bloody fluid, the mediastinal adenopathy, and the lymphocytosis in the pericardial fluid. An adenosine deaminase assay, which has been used to identify tuberculosis, was uninterpretable due to the amount of blood in the fluid . Initially, we discharged the patient under the assumption that the tamponade was most likely due to a viral cause, although Coxsackie and adenoviral titers were negative. It was the late appearance of circulating immunoblasts that finally pointed towards a leukemic process.
Up to 20% of patients with a known malignancy are found to have pericardial involvement upon autopsy . However, tamponade as an initial manifestation of malignancy is relatively uncommon. A review of 78 cases revealed that 60% of such cases stemmed from lung carcinomas whereas only 9% originated from leukemia or lymphoma . The evolution of pericardial effusion is often due to infiltration of malignant cells as well as lymphatic obstruction; our patient clearly had pericardial involvement of leukemia on histology.
A PubMed search beginning in 1979 using the keywords "chronic lymphocytic leukemia and pericarditis, pericardial tamponade, pericardial effusion" identified only a handful of cases that have documented cardiac infiltration in patients with CLL. One case describes tamponade and pericardial effusion as the initial presentation of lymphosarcoma cell leukemia, which is morphologically very similar to CLL . This patient presented with dyspnea and mild abdominal distention and had a leukoctye count of 23,200/uL. Three other cases described tamponade related to previously documented CLL in patients presenting with dyspnea [3, 7, 8]. Finally, one case report detailed constrictive pericarditis in a patient with B-cell chronic lymphatic leukemia whose initial complaint was also breathlessness . The leukocyte count in all the CLL patients in these reports was much higher (282,000 to 827,000/uL) than our patient's (18,100/uL).
She subsequently continued follow-up with a primary oncologist regarding the status of her CLL. She was found to be Rai stage I and one-year post discharge had not received CLL treatment (because she had normal platelet and hemoglobin levels and remained asymptomatic). Management of pericardial effusions as initial presentations of malignancy is not well established, though some reports have suggested systemic chemotherapy and radiotherapy prior to pericardiocentesis to avoid potential complications . In our patient, because the diagnosis of leukemia was unknown, pericardiocentesis was performed without chemotherapy and has provided sustained relief of her dyspnea for the past year.
To the best of our knowledge this is the first reported case of CLL presenting as pericardial tamponade. The diagnosis was confounded by the similarities to tuberculous pericarditis and the modest degree of leukocytosis. The appearance of peripheral immunoblasts was the key to the ultimate diagnosis, which we confirmed by demonstrating CD5 (+) and CD20 (+) lymphocytes using flow cytometry on the blood and immunohistochemistry on the pericardial tissue.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- McDonnell PJ, Mann RB, Bulkley BH: Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer. 1982, 49: 944-951. 10.1002/1097-0142(19820301)49:5<944::AID-CNCR2820490519>3.0.CO;2-C.View ArticlePubMedGoogle Scholar
- Chu JY, Demello D, O'Connor DM, Chen SC, Gale GB: Pericarditis as presenting manifestation of acute nonlymphocytic leukemia in a young child. Cancer. 1983, 52: 322-324. 10.1002/1097-0142(19830715)52:2<322::AID-CNCR2820520222>3.0.CO;2-U.View ArticlePubMedGoogle Scholar
- Giannini O, Schonenberger-Berzins R: Fulminant cardiac tamponade in chronic lymphocytic leukaemia. Ann Oncol. 1997, 8: 1168-1169. 10.1023/A:1008249320333.View ArticlePubMedGoogle Scholar
- Imazio M, Demichelis B, Parrini I, Favro E, Beqaraj F, Cecchi E, Pomari F, Demarie D, Ghisio A, Belli R, Bobbio M, Trinchero R: Relation of acute pericardial disease to malignancy. Am J Cardiol. 2005, 95: 1393-1394. 10.1016/j.amjcard.2005.01.094.View ArticlePubMedGoogle Scholar
- Atar S, Chiu J, Forrester JS, Siegel RJ: Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s?. Chest. 1999, 116: 1564-1569. 10.1378/chest.116.6.1564.View ArticlePubMedGoogle Scholar
- Habboush HW, Dhundee J, Okati DA, Davies AG: Constrictive pericarditis in B cell chronic lymphatic leukaemia. Clin Lab Haematol. 1996, 18: 117-119. 10.1046/j.1365-2257.1996.00164.x.View ArticlePubMedGoogle Scholar
- Samara MA, Brennan JM, Van Besien K, Larson RA: Cardiac tamponade in a patient with chronic lymphocytic leukemia. Leuk Lymphoma. 2007, 48: 829-832. 10.1080/10428190601142849.View ArticlePubMedGoogle Scholar
- Almeda FQ, Adler S, Rosenson RS: Metastatic tumor infiltration of the pericardium masquerading as pericardial tamponade. Am J Med. 2001, 111: 504-505. 10.1016/S0002-9343(01)00897-X.View ArticlePubMedGoogle Scholar
- Tuon FF, Litvoc MN, Lopes MI: Adenosine deaminase and tuberculous pericarditis--a systematic review with meta-analysis. Acta Trop. 2006, 99: 67-74. 10.1016/j.actatropica.2006.07.004.View ArticlePubMedGoogle Scholar
- Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons M: Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart. 1996, 75: 67-71. 10.1136/hrt.75.1.67.View ArticlePubMedPubMed CentralGoogle Scholar
- Muir KW, Rodger JC: Cardiac tamponade as the initial presentation of malignancy: is it as rare as previously supposed?. Postgrad Med J. 1994, 70: 703-707. 10.1136/pgmj.70.828.703.View ArticlePubMedPubMed CentralGoogle Scholar
- Levitt LJ, Ault KA, Pinkus GS, Sloss LJ, McManus BM: Pericarditis and early cardiac tamponade as a primary manifestation of lymphosarcoma cell leukemia. Am J Med. 1979, 67: 719-723. 10.1016/0002-9343(79)90273-0.View ArticlePubMedGoogle Scholar
- Leung WH, Tai YT, Lau CP, Wong CK, Cheng CH, Chan TK: Cardiac tamponade complicating leukaemia: immediate chemotherapy or pericardiocentesis?. Postgrad Med J. 1989, 65: 773-775. 10.1136/pgmj.65.768.773.View ArticlePubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.